a6087121.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): October 29, 2009

PHARMERICA CORPORATION
(Exact Name of Registrant as Specified in Its Charter)

         
Delaware
  
001-33380
  
87-0792558
(State or Other Jurisdiction
of Incorporation)
  
(Commission
File Number)
  
(IRS Employer
Identification No.)
 

 
1901 Campus Place
Louisville, Kentucky 40299
(Address of principal executive offices)  (Zip Code)

 
(502) 627-7000
(Registrant’s telephone number, including area code)
 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
     
o   
  
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
     
o   
  
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
     
o   
  
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
     
o   
  
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 
 
 
 
Item 2.02   Results of Operations and Financial Condition.

On October 29, 2009, PharMerica Corporation (the “Company”) issued a press release announcing results of operations for the third quarter and nine months ended September 30, 2009, a copy of which is attached as Exhibit 99.1

 
Item 9.01   Financial Statements and Exhibits.

(d) Exhibits
 
99.1   Press Release of PharMerica Corporation dated October 29, 2009.

 
 
 
SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.                                                                              
 
 
PHARMERICA CORPORATION
  
       
Date: October 29, 2009
By:
/s/ Michael J. Culotta
  
   
Michael J. Culotta
  
   
Executive Vice President and Chief Financial Officer
  
       
 

 
 
Exhibit Index
 
 
Exhibit No.   Description
99.1   Press Release of PharMerica Corporation dated October 29, 2009.